OBJECTIVE: Glioblastoma Multiforme (GBM), one of the most malignant forms of primary brain tumors, is characterized by its highly heterogenous genetic composition, aggressive infiltration of surrounding tissue, and resistance to current treatments. Gene expression analysis has characterized GBM into four main types, with a significant portion belonging to the Classical subtype, typified by overexpression and/or mutation of the epidermal growth factor receptor (EGFR). Also common to this subtype of GBM is the loss of crucial tumor suppressor genes Ink4A/ARF and PTEN, which contribute to the invasive nature and unregulated proliferation that underlie the GBM pathology. The high rate of tumor recurrence post treatment with surgical resection, chemotherapy, and radiation has driven the pursuit of more effective molecularly targeted therapies. This study was undertaken to determine the effects of two types of small molecule tyrosine kinase inhibitors on cells overexpressing wild-type EGFR in the context of their respective complements of tumor suppressor genes. METHODS: Several cell lines were established from mouse models of EGFR wild-type (EGFRWT) driven gliomagenesis and treated with 10 μM of type I tyrosine kinase inhibitors Gefitinib (Iressa®, Astra Zeneca), CI-1033 (Canertinib, Pfizer), or Dimethyl Sulfoxide vehicle. Cells were exposed to each drug treatment as part of a time course ranging from 0 to 24 hours and then evaluated by trypan blue exclusion and Western blot analysis for cell viability and molecular and biochemical effects respectively. RESULTS: Evaluation of cell viability indicated that CI-1033 caused a greater increase in cell death than gefitinib when compared to control treated cells regardless of the tumor suppressors lost. Gefitinib was found to cause cell death only in cells expressing the PTEN tumor suppressor whereas CI-1033 showed similar levels of cell death for cells deficient in Ink4A/ARF or both Ink4A/ARF and PTEN tumor suppressors. Western blot analysis revealed that CI-1033 more effectively inhibited EGFR compared to gefitinib. Treatment with both gefitinib and CI-1033 effectively blocked phosphorylation of EGFR, but this effect was less pronounced with gefitinib treatment. Further analysis of downstream signaling molecules showed a greater presence of cleaved caspase 3, a hallmark of apoptosis, in gefitinib treated cells expressing PTEN than in those cells treated with CI-1033. Cells deficient in both Ink4A/ARF and PTEN did not demonstrate any induction of cleaved caspase 3 following either treatment. CONCLUSIONS: Based on the significant differences in cell viability between treatments, CI-1033 is an overall more effective inhibitor of EGFRWT expressing cells lacking PTEN, while gefitinib and CI-1033 were found to be similarly effective in cells expressing PTEN. The results of western blot analysis indicate that total and irreversible EGFR inhibition may be necessary to induce cell death in a manner that effectively terminates downstream cell signaling. It is likely that CI-1033, unlike gefitinib, induces apoptosis in a caspase-independent manner, which may be one of the many differences in downstream effects produced by these two drugs. Further research is necessary to determine the extent to which each inhibitor shuts down proliferative cell signaling pathways such as PI3K-AKT and MEK-ERK signaling pathways downstream of EGFR. Overall, these data indicate that genotype plays an important role in the determination of therapeutic response and may aid in the evaluation of clinical prognoses.

Baz/PAR3 is a key regulator of epithelial cell polarity (ECP). To identify proteins functioning with Baz, I completed a baz genetic interaction screen by localizing 15 GFP-tagged candidates. Then I tested the role of a top candidate, dASAP (Drosophila Arf GTPase-activating protein with SH3 domain, Ankyrin repeat and PH domain), in Drosophila ECP. To determine whether dASAP might interact with polarity players, I defined the localization of dASAP throughout embryogenesis with GFP-tagged proteins and an anti-dASAP antibody. To study how loss of dASAP function affects ECP, I generated a deletion allele by imprecise P-element excision. To evaluate how each of the six domains of dASAP contributes to its localization and functions, I generated constructs deleting each domain. I found associations between dASAP, actin and the apical domain. The six domains may act redundantly to localize dASAP, although interactions between domains may affect the degree of membrane association.

Baz/PAR3 is a key regulator of epithelial cell polarity (ECP). To identify proteins functioning with Baz, I completed a baz genetic interaction screen by localizing 15 GFP-tagged candidates. Then I tested the role of a top candidate, dASAP (Drosophila Arf GTPase-activating protein with SH3 domain, Ankyrin repeat and PH domain), in Drosophila ECP. To determine whether dASAP might interact with polarity players, I defined the localization of dASAP throughout embryogenesis with GFP-tagged proteins and an anti-dASAP antibody. To study how loss of dASAP function affects ECP, I generated a deletion allele by imprecise P-element excision. To evaluate how each of the six domains of dASAP contributes to its localization and functions, I generated constructs deleting each domain. I found associations between dASAP, actin and the apical domain. The six domains may act redundantly to localize dASAP, although interactions between domains may affect the degree of membrane association.

Organelles within the endomembrane system of all eukaryotic cells exchange membrane lipids and proteins using membrane-bound transport vesicles. This highly conserved vesicular transport process is essential for life and is highly regulated. Much of this regulation is provided by small monomeric GTP-binding proteins such as Arf and Arl that act as molecular switches, cycling between inactive GDP-bound and active GTP-bound states. This cycle of GTP binding and hydrolysis is controlled by guanine-nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs), respectively. I have investigated regulatory interactions involving two ArfGAPs, Age1 and Gcs1, involved in post-Golgi vesicular transport in the budding yeast Saccharomyces cerevisiae. In yeast, the Age2 + Gcs1 ArfGAP pair is essential and facilitates post-Golgi transport. I found that overexpression of either the poorly characterized ArfGAP Age1 or the Sfh2 phosphatidylinositol-transfer protein can bypass the requirement for Age2 and Gcs1. Indeed, endogenous Age1 is required for efficient Sfh2-bypass. Moreover, the yeast phospholipase D protein, Spo14, which is activated by Sfh2 and regulates membrane lipid composition, is required for Age1 to effectively alleviate the deleterious effects of defective Age2 + Gcs1 function. My findings suggest that Age1 is regulated by membrane lipid composition and can provide ArfGAP function for post-Golgi transport. Gcs1 is involved in multiple vesicular transport stages, is a dual-specificity GAP for both Arf and Arl1 proteins and, as shown here, also has functions independent of its GAP activity. The absence of Gcs1 causes cold sensitivity for growth and endocytic transport. The cold sensitivity of cells lacking Gcs1 is alleviated by the elimination of either the Arl1 or Ypt6 vesicle-tethering pathway at the trans-Golgi, or by overexpression of Imh1, an effector of the Arl1 pathway. I found elimination of the Ypt6 pathway also prevents Arl1 activation and membrane localization, that Arl1 binding by Imh1 is necessary and sufficient for alleviation, and that the Gcs1 function required for growth and transport in the cold is independent of any GAP activity. My findings suggest that in the absence of this GAP-independent function of Gcs1 the resulting dysregulated Arl1 causes the gcs1? defects through the sequestration of a yet-to-be-determined cellular factor.

Made available in DSpace on 2014-06-11T19:27:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2007-12-13Bitstream added on 2014-06-13T19:35:39Z : No. of bitstreams: 1 galvao_sfv_me_botfm_prot.pdf: 503261 bytes, checksum: 325320966be17182448387b64650477c (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / A Insuficiência Renal Aguda apresenta uma alta incidência em pacientes internados em hospitais terciários, principalmente em Unidades de Terapia Intensiva, estando associada a elevada mortalidade. Este trabalho tem como objetivos descrever a população de pacientes internados no Hospital das Clínicas de Faculdade de Medicina de Botucatu - UNESP com diagnóstico de Insuficiência Renal Aguda atendidos pelo Grupo de Interconsultas do Serviço de Nefrologia e avaliar os fatores de risco associados ao óbito nestes pacientes. Foram acompanhados 946 pacientes no período de abril de 2002 a dezembro de 2006, todos maiores de 12 anos, com diagnóstico de Necrose Tubular Aguda e internados nas diferentes enfermarias e Unidades de Terapia Intensiva do Hospital das Clínicas, exceto na Pediatria e Nefrologia. Insuficiência Renal Aguda foi definida como um aumento de creatinina sérica de pelo menos 30% de seu valor basal em período mínimo de 48 horas. A média de idade foi de 61,8 ± 16,7 anos, com predomínio do sexo masculino (61,9%). Pacientes provenientes de enfermarias clínicas foram mais freqüentes (62,1%), sendo que 15,9% estavam internados na cardiologia e 15,2% na clínica médica geral, enquanto 13,3% estavam internados na enfermaria de gastroenterologia cirúrgica. 46,1% estavam internados em Unidades de Terapia Intensiva e a sepse esteve presente em 9,7% dos casos. Isquemia (51,2%) foi a etiologia mais freqüente e o tempo de acompanhamento nefrológico apresentou mediana de 7,5 dias, com intervalo interquartílico de 4 a 14 dias. / Acute Renal Failure (ARF) present a high incidence in critically ill patients taken into tertiary care hospitais, mostly in the Intensive Care Unit (ICU) patients, were also associate with great mortality rate. The objective of this work was to describe the population of patients hospitalized in the School Medicine, Botucatu- UNESP with diagnosis of ARF, attended by Group of - Interconsults of Service Nephrology and to evaluate the risk factors associate with death in this patients. This was a cohort study which evaluated 946 patients with ARF, from April 2002 to December 2006, was included patients older than 12 years, with diagnosis of ARF due to Acute Tubular Necrosis (ATN) and hospitalized in wards and ICU of HC- FMBUNESP (except in the Pediatrics and Nephroloy wards). ARF was defined as serum creatinine at least 30% above basal value from 48 hours at minimum. The average of age was 61,8 ± 16,7 years, with predominantly masculine gender (61,9%). 15,9% were hospitalized in the cardiology and 15,2% in the clinical medical, while 13,3% were hospitalized in the gastroenterology surgical ward. 46,1% of patients were hospitalized in ICU and the sepsis was present in 9,7% of the cases. Ischemia was the etiology more frequent (51,2%) and the time of accompaniment nephrologic presented an median of 7,5 days (4 - 14).

Indiana University-Purdue University Indianapolis (IUPUI) / At the present time, gentamicin is used in the treatment of both Gram-negative and Gram-positive bacterial infections. However, the poorly understood side effect of nephrotoxicity is a serious problem and is one of the dose-limiting factors in the use of gentamicin. In our model system, Saccharomyces cerevisiae, which is relatively resistant to gentamicin, at least 20 genes are required for gentamicin resistance. Inspection of the physical and genetic interactions of the gentamicin sensitive mutants reveals a network centered on the ARF pathway which plays a key role in the regulation of retrograde trafficking. Our studies show that arf1ts arf1Δ arf2Δ cells, gea1ts gea1Δ gea2Δ cells, and gcs1ts gcs1Δ glo3Δ cells are all hypersensitive to gentamicin which indicates that impaired Arf1 function causes yeast cells to become hypersensitive to gentamicin. As evidence, cellular CPY trafficking and processing are blocked by the presence of gentamicin in some of these mutants. Interestingly, gentamicin can directly affect the level of the GTP-bound form of Arf1 in a cell growth phase-dependent manner; even though total Arf1 levels in S. cerevisiae are not affected. As predicted, we also find that gentamicin-bound resin can enrich both yeast Arf1-TAP protein and rat Arf1 protein in vitro. With the help of mass spectrometry, we also generated a gentamicin-binding protein list. Gentamicin hypersensitivity is also observed in S. cerevisiae double deletion strains that lack both ARF1 and ARF2 but are kept alive by the presence of hARF4 or bARF1. Increased -1 programmed ribosomal frameshifting efficiency is also observed in cells treated with gentamicin. Finally, a comparison of a gentamicin mixture and four of the gentamicin congeners reveals that gentamicin C1 is less toxic than other gentamicin congeners or the gentamicin total mixture.

La formation des fruits charnus est un processus de développement impliquant trois stades principaux : (i) la transition fleur/fruit ou nouaison, (ii) la croissance et enfin (iii) la maturation des fruits. Chacune de ces étapes correspond à une transition développementale associée à d’importants changements physiologiques et structurels. Parmi toutes les hormones, l’auxine est connue pour jouer un rôle important dans l‟initiation et la coordination du processus de nouaison et des phases précoces de développement du fruit. La mise en place de la réponse à l‟auxine nécessite l‟intervention de facteurs de transcription appartenant à la famille des ARF (Axin Response Factor) connus pour réguler l‟expression des gènes de réponse précoce à l‟hormone en se liant aux Cis-éléments de type AuxRE (Auxin Response Element) possédant le motif conservé de réponse à l‟auxine. Les ARF sont de ce fait des candidats forts pour faire partie du mécanisme moléculaire par lequel l’auxine intervient dans le processus de nouaison. Le projet de recherche réalisé au cours de la thèse a permis d‟isoler et de caractériser au total 22 gènes Sl-ARF chez la tomate (Solanum lycopersicum), la plante modèle pour l’étude du développement et de la maturation des fruits charnus. Les gènes Sl-ARF montrent des profils d‟expression distincts selon les tissus et organes considérés, suggérant des fonctions spécifiques pour les membres de cette famille multigénique. Il est de plus montré que certains gènes Sl-ARF sont régulés à la fois par l’auxine et par l’éthylène, suggérant qu‟ils participent potentiellement au dialogue entre les voies de signalisation des deux hormones. L’expression transitoire a révélé la capacité des Sl-ARF à agir comme activateur ou répresseur transcriptionnel des gènes de réponse à l’auxine. L‟étude des profils d’expression globale, réalisée par RNA-seq à l‟échelle du génome entier, a révélé pour la première fois l‟existence d‟un niveau important de régulation par épissage alternatif des ARFs pendant la transition fleur-fruit. La localisation nucléaire des protéines Sl-ARF8A / B a été déterminée par fusion avec le gène rapporteur GFP puis expression dans un système "signle cell". L‟étude d’expression a révélé des profils distinctifs entre ARF8A et ARF8B avec une augmentation notable des transcrits Sl-ARF8A suite à la pollinisation des fleurs. Le rôle physiologique du gène Sl-ARF8A a été par la suite abordé par une approche de génétique inverse fournissant un nouvel éclairage sur les événements moléculaires qui sous-tendent la mise à fruit. La surexpression de Sl- ARF8 dans la tomate engendre des phénotypes pléiotropiques touchant la croissance - 4 - végétative (réduction de la taille des plantes, altération du développement racinaire et des tiges latérales) et l‟appareil reproducteur avec la formation de fruits parthénocarpiques (absence de graines). L’analyse histologique a révélé une modification notable du placenta et des ovules chez les lignées de sur-expression de Sl-ARF8 et les études par RNA-Seq ont identifié plus de 2632 gènes différentiellement exprimés chez les surexpresseurs par comparaison avec les lignées non transformées. Au total, l‟étude réalisée au cours de la thèse fournit une description exhaustive de la famille des ARF chez la tomate et une caractérisation fonctionnelle du gène Sl-ARF8 qui souligne son rôle comme figure centrale du mécanisme de contrôle de la nouaison des fruits. / The making of a fleshy fruit is a developmental process involving three main stages known as (i) fruit set, (ii) fruit growth and (ii) fruit ripening each corresponding to a transition step associated with major physiological and structural changes. Among other hormones, auxin is known to play a dynamic role in triggering and coordinating the changes associated with the process of fruit set and early fruit development. Auxin responses are mediated at the transcriptional level by Auxin Response Factors (ARFs) which regulate early auxin-responsive genes by specific binding to TGTCTC Auxin Response Elements (AuxREs). ARFs are therefore good candidates for being among the components of the molecular mechanism by which auxin mediates the fruit set. In the present study, a total of 22 Sl-ARF genes have been isolated and characterized in tomato (Solanum lycopersicum), a model plant for the study of fleshy fruit development and ripening. Expression profiling revealed distinctive patterns for Sl-ARF genes in different tomato tissues. Hormone treatment indicated that Sl-ARFs can be regulated both by auxin and ethylene with Sl-ARF2B, 5 and 9 likely to be involved in the cross-talk between the two hormones. Transient expression using a single cell system uncovered the ability of Sl- ARFs to act either as transcriptional activator or repressor in regulating the expression of auxin-responsive genes. Genome-wide expression profiling performed by deep RNASequencing revealed for the first time the importance of the alternative splicing mode of regulation of ARF genes during tomato fruit set. The physiological significance of two closely related Sl-ARFs, Sl-ARF8A and Sl-ARF8B, was addressed in the present study via a reverse genetics approach providing new insight on the molecular events underlying tomato fruit set. Fusion to GFP reporter gene indicated that both Sl-ARF8A/B proteins are nuclear localized. Expression analysis by RT-qPCR revealed some distinctive features between Sl-ARF8A and Sl-ARF8B with a notable increase in Sl-ARF8A transcript upon flower pollination. Over-expression of Sl-ARF8A/B in tomato resulted in pleiotropic phenotypes, including dwarf plants, altered root and lateral shoot development and parthenocarpic fruits (seedless). Histological analysis revealed altered placenta and ovules development in SlARF8A-OX flowers and RNA-Seq profiling identified over 2632 differentially expressed (DE) genes in SlARF8A-OX flower buds compared to wild type control plants. Considering the dramatic change in gene expression of genes related to auxin, jasmonate and ethylene displayed in SlARF8A-OX lines, these phytohormones are likely to play an active role in coordinating the fruit set process. Altogether, the present - 6 - study provided a comphensive description of the tomato ARF gene family and a functional characterization of Sl-ARF8 defining this ARF member as a central figure of the control mechanism of the fruit set process.

Le facteur de transcription E4F1 fût initialement identifié comme une cible cellulaire de l'oncoprotéine virale E1A au cours de l'infection par l'adénovirus sérotype V. E4F1 est une protéine multifonctionelle essentielle au cours du développement embryonnaire précoce et joue des rôles importants dans l'équilibre entre prolifération/survie de différents types cellulaires, notamment des cellules souches. Au niveau moléculaire, E4F1 possède des activités transcriptionelles intrinsèques mais possède également une activité ubiquitine E3 ligase atypique dirigée contre d'autres facteurs de transcription tel que le suppresseur de tumeur p53. Récemment, il a été démontré qu'E4F1 régule les voies oncogéniques impliquant p53 et Rb qui jouent un rôle essentiel au cours de la sénescence cellulaire. La sénescence, qui est définie par un arrêt irréversible du cycle cellulaire, est considéré comme un mécanisme suppresseur de tumeurs essentiel au cours des phases précoces du développement tumoral. L'objectif de ma thèse a été d'évaluer le rôle d'E4F1 au cours de la sénescence cellulaire. Au travers d'études menées sur des fibroblastes humains primaires et des fibroblastes embryonnaires murins dérivés de souris génétiquement modifiées pour le gène E4F1, j'ai examiné comment la perturbation des activités d'E4F1 module l'initiation ou le maintien de la sénescence prématurée induit par l'oncogène RAS, la déplétion du membre de la famille polycomb Bmi1, ou par les dommages à l'ADN. Mes résultats suggèrent que la déplétion d'E4F1 protège partiellement contre l'induction de la sénescence alors que l'expression ectopique d'E4F1 accélère la sénescence par son implication dans la voie INK4A/ARF-p53. L'ensemble de mes résultats supportent la notion qu'E4F1 est un régulateur important de la sénescence cellulaire. / E4F1 was originally identified as a cellular target of the viral oncoprotein E1A during adenoviral infection. E4F1 is a multifunctional protein that is essential during early embryogenesis and plays important roles in the proliferation/survival balance of different cell types including stem cells. At the molecular level, E4F1 exhibits intrinsic transcriptional activities but also an ubiquitin E3 ligase function that targets other transcription factors, including the p53 tumor suppressor. Recent studies indicate that E4F1 impinge on several pathways, including the Rb and p53 pathways, that are known to influence cellular senescence, an irreversible state of cell cycle arrest that is considered to be an essential tumor suppressor mechanism during early steps of tumorigenesis. The objective of my thesis was to evaluate the roles of E4F1 during cellular senescence. Using human primary fibroblasts and mouse embryonic fibroblasts derived from genetic ally engineered mouse models, I investigated how perturbations of E4F1 activities modulated the initiation or the maintenance of premature senescence induced by oncogenic Ras, depletion of the polycomb member Bmi1 or DNA damage. My results suggest that E4F1 depletion partly protects from the induction of cellular senescence whereas ectopic expression of E4F1 accelerates premature senescence through its implication in the Ink4a/ARF-p53 pathway. Altogether, my results support the notion that E4F1 is an important regulator of cellular senescence.

The dissertation is devoted to the notion of preventive diplomacy. In the first part, various theoretical approaches to the term are discussed, especially regarding the position of preventive diplomacy in the cycle of conflict, and its instruments. A brief overview of regional arrangements and their role in preventive diplomacy is provided, too, since the second main part of the work focuses on the ASEAN Regional Forum (ARF) and its proclaimed intention to introduce preventive diplomacy in the region. Nonetheless, as the study shows, the ARF participants have not yet resorted to the development of preventive diplomacy. The objective of the dissertation is twofold: besides providing a synthesis and systemization of theoretical approaches to preventive diplomacy, it aims to identify the main obstacles hindering the ARF to implement effective measures of preventive diplomacy. In this respect, it is argued that it is both the set of norms also known as ASEAN Way and the Chinese negative stance that constitute the major reason of ARF's inability to proceed to the stage of preventive diplomacy.

Im ersten Teil dieser Arbeit wurden mittels molekular-zytogenetischer Methoden die chromosomalen Aberrationen in c-myc aktivierten ARFnull- und INK4a/ARFnull-Mauslymphomen untersucht. Die zytogenetischen Ergebnisse wurden mit dem Therapieverlauf der Mäuse nach Cyclophosphamid-Behandlung verglichen. In den ARFnull-Lymphomen erkannten wir den Gewinn des Chromosoms 14 als einen Marker für gute und den Gewinn des Chromosoms 6 als Marker für schlechte Behandlungserfolge. Auf den Chromosomen 6 und 14 der Maus liegen demnach bisher unbekannte Gene, welche für die Wahl der Behandlungsmethode ARF-defizienter Tumore von entscheidender Bedeutung sind. Der zweite Teil der Arbeit befaßt sich mit Common Fragile Sites (CFS), die als "hot spots" für chromosomale Brüche und Umbauten in Tumorgenese und Karyotypevolution diskutiert werden. CFSs treten als seltene Lücken im Chromatin oder als partiell deletierte bzw. rearrangierte Chromosomen auf. Ihre Zahl wird durch Zugabe von Replikations-hemmenden Chemikalen, wie Aphidicolin (APC), erheblich gesteigert. Wir untersuchten die CFS-Expression in Lymphozytenkulturen der Mausstämme BALB/c und C57BL/6. Die APC-induzierten CFS-Häufigkeiten der Chromosomenbanden wiesen im Vergleich zwischen beiden Mausstämmen eine signifikante Korrelation und damit eine starke Konservierung auf. Ebenfalls wurde zwischen Maus / Mensch-syntenischen Bereichen eine Konservierung der CFS-Häufigkeiten detektiert. Die Tendenz zur CFS-Bildung ist also ein spezifisches Merkmal jedes chromosomalen Abschnitts, das evolutionär konserviert ist. Weiterhin wurden einzelne CFSs mit molekular-zytogenetischen Methoden genauer kartiert. Auf diese Weise beschrieben wir erstmals eines der zehn häufigsten CFSs menschlicher Lymphozyten, FRA7K, und erweiterten somit die Anzahl molekular charakterisierter humaner CFSs auf insgesamt 13. Für fünf dieser CFSs analysierten wir mittels FISH-Analyse die homologen Bereiche im Mausgenom hinsichtlich ihrer CFS-Expression. Die beobachteten Läsionen traten jeweils in exakt den entsprechenden Sequenzen auf. Vereint man diese fünf Beispiele (FRA2G/Fra2D, FRA7G/Fra6A3.1, FRA7H/Fra6B1, FRA7K/Fra12C1 und FRA9E/Fra4C2) mit bekannten Homologen aus der Literatur, so wurde für insgesamt acht CFSs eine Konservierung zwischen Mensch und Maus auf molekularer Ebene gefunden. Trotz zahlreicher Untersuchungen ist der zelluläre Mechanismus, der die Ausbildung von CFSs an spezifischen Stellen des Genoms bewirkt, bis heute weitgehend unklar. Bekannt ist, daß CFSs durch Replikationsinhibition induziert werden und in Metaphase-Zellen sichtbar werden, welche DNA-Replikations-Checkpoints unterlaufen haben.Sämtliche jüngeren Studien beschrieben Inseln erhöhter DNA-Helix-Flexibilität (Schwankungen im Biegungswinkel des Moleküls) in den Bereichen von CFSs. Wir berechneten die DNA-Helix-Flexibilität entlang der Sequenz für alle molekular kartierten humanen und Maus-CFSs sowie für stabile Kontrollregionen. Anders als in der Literatur beschrieben, fanden wir für Mensch und Maus, daß sich CFSs und Kontroll-DNAAbschnitte in ihrer Dichte an Inseln mit erhöhter DNA-Helix-Flexibilität nicht unterschieden. Nahezu alle Regionen der häufigen molekular charakterisierten CFSs umfassen große Gene, deren Exons mehr als 650 kb genomische Sequenz überspannen. Im Gegensatz dazu traten große Gene in den stabilen Kontrollregionen deutlich seltener auf. Öffentlich zugängliche RNA-Expressionsdaten dieser Gene zeigten, daß CFSs bevorzugt in Bereichen mit transkriptionell aktiven, großen Genen entstehen. Darauf und auf dem Wissen aus der Literatur begründen wir die Hypothese, daß eine Blockierung der DNAReplikationsgabel, vor allem in Bereichen großer transkriptionell aktiver Gene - eventuell begründet durch deren offenere Chromatinstruktur - und das anschließende Unterlaufen von Zellzyklus-Checkpoints an der Bildung von CFSs und damit in einem Anstieg von Doppelstrangbrüchen beteiligt sind.